Skip to content
healthcare.dev

Prostazen

NDC 80353-702, Enlarged Prostate, Prostatic Utricle Function, and Prostatitis Recovery, capsule, from HCBIOPHARM LLC.

Product NDC
80353-702
Status
Listed
Labeler
HCBIOPHARM LLC
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
UNAPPROVED HOMEOPATHIC
Application
—
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/80353-702 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • SAW PALMETTO1 [hp_X]/1
  • RUBIA CORDIFOLIA ROOT1 [hp_X]/1
  • REYNOUTRIA JAPONICA ROOT1 [hp_X]/1
Package NDCNDC-11Package
80353-702-01803530702011 BOTTLE in 1 BOX (80353-702-01) / 1 CAPSULE in 1 BOTTLE (80353-702-02) / 60 CAPSULE in 1 CAPSULE (80353-702-03)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 80353-702 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/80353-702 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 80353-702. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.